OBJECTIVES: To determine the clinical presentation, predisposing factors, complications, and treatment outcomes of otomycosis.
STUDY DESIGN AND SETTING: Retrospective review of 132 patients with a clinical diagnosis of otomycosis treated from 1998 to 2004 in an academic otology practice.
RESULTS: Otalgia and otorrhea were the most common presenting complaints (48%). Prior otologic procedures increase the risk of developing otomycosis. Residual disease was observed in 13% and recurrence in 15% of the subjects. The presence of a mastoid cavity was associated with higher recurrent and residual disease rates. Topical ketoconazole, cresylate otic drops, and aluminum acetate otic drops were all relatively effective with >80% resolution rate on initial application, although topical ketoconazole had a higher resolution rate and lower rate of disease recurrence.
CONCLUSIONS AND SIGNIFICANCE: Otomycosis can usually be diagnosed by clinical examination and often occurs in the setting of persistent otorrhea. Complications are not uncommon but usually resolve with application of appropriate topical antifungal agents. Eradication of disease is more difficult in the presence of a mastoid cavity.
Get full access to this article
View all access options for this article.
References
1.
MuglistonTO'DonoghueG.Otomycosis: a continuing problem. J Laryngol Otol1985;99:327–33.
2.
KaurRMittalNKakkarM, et al. Otomycosis: a clinicomycologic study. Ear Nose Throat J2000;79:606–9.
3.
JadhavVJPalMMishraGS.Etiological significance of Candida albicans in otitis externa. Mycopathologia2003;156:313–5.
4.
VennewaldISchonlebeJKlemmE.Mycological and histological investigations in humans with middle ear infections. Mycoses2003; 46:12–8.
5.
SternJCLucenteFE.Otomycosis. Ear Nose Throat J1988; 67: 804–10.
6.
FordESMokdadAHGilesWH, et al. Geographic variation in the prevalence of obesity, diabetes, and obesity-related behaviors. Obes Res2005;13:118–22.
7.
PradhanBTuladharNRAmatyaRM.Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Ann Otol Rhinol Laryngol2003;112:384–7.
8.
SoodVPSinhaAMohapatraLN.Otomycosis: a clinical entity clinical and experimental study. J Laryngol Otol1967;81:999–1004.
9.
YoussefYAAbdouMH.Studies on fungus infection of the external ear. I. Mycological and clinical observations. J Laryngol Otol1967; 81: 401–12.
10.
YoussefYAAbdouMH.Studies on fungus infection of the external ear. II. on the chemotherapy of otomycosis. J Laryngol Otol1967; 81: 1005–12.
11.
SternJCShahMKLucenteFE.In vitro effectiveness of 13 agents in otomycosis and review of the literature. Laryngoscope1988;98:1173–7.
del PalacioACuetaraMSLopez-SusoMJ, et al. Randomized prospective comparative study: short-term treatment with ciclopiroxolamine (cream and solution) versus boric acid in the treatment of otomycosis. Mycoses2002;45:317–28.
14.
PauloseKOAl KhalifaSShenoyP, et al. Mycotic infection of the ear (otomycosis): a prospective study. J Laryngol Otol1989;103:30–5.
15.
HurstWB.Outcome of 22 cases of perforated tympanic membrane caused by otomycosis. J Laryngol Otol2001;115:879–80.
16.
OzcanMOzcanKMKaraarslanA, et al. Concomitant otomycosis and dermatomycoses: a clinical and microbiological study. Eur Arch Otorhinolaryngol2003;260:24–7.
17.
JackmanAWardRAprilM, et al. Topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol2005;69:857–60.
18.
SchraderNIsaacsonG.Fungal otitis externa: its association with fluoroquinolone eardrops. Pediatrics2003;111:1123.
19.
MartinTJKerschnerJEFlanaryVA.Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol2005; 69:1503–8.
